Patent: 6,884,616
✉ Email this page to a colleague
Summary for Patent: 6,884,616
Title: | DNA-construct for the tissue-specific expression of a blood coagulation factor |
Abstract: | A DNA-construct has been disclosed which is suitable for a tissue-specific expression of a blood coagulation factor like Factor IX, which comprises a DNA coding for an amino acid sequence of a blood coagulation factor and a DNA coding for a promoter which is specific for the expression in hematopoietic cells. |
Inventor(s): | Negrier; Claude (Irigny, FR), Rodriguez; Marie Helene (Lyon, FR), Enjolras; Nathalie (Caluire, FR) |
Assignee: | ZLB Behring GmbH (Marburg, DE) |
Application Number: | 09/559,344 |
Patent Claims: | see list of patent claims |
Details for Patent 6,884,616
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2019-04-27 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2019-04-27 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2019-04-27 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |